Conversations surrounding initial public offerings (IPOs) have gradually become commonplace. Whether at family dinners, tea breaks among colleagues, or buzzing group chats on Telegram and WhatsApp, discussions often revolve around one key figure – the grey market premium (GMP). This seemingly straightforward indicator spreads rapidly and is often perceived as a quick gauge of an IPO’s potential listing strength.
However, many new investors may not fully grasp the origins and unreliability of GMP. In an effort to shed light on why GMP holds significant sway over novice investors, insights were gathered from industry experts Tarun Singh, founder of Highbrow Securities, and Ratiraj Tibrewal, CEO of Choice Capital.
GMP stands for the unofficial price at which IPO shares are traded privately before their official listing. These transactions occur off-market, involving a select group of participants, devoid of oversight from regulatory bodies. Tibrewal emphasizes that GMP, being informal and unregulated, often reflects speculative sentiment rather than genuine demand. He cites the case of Lenskart, where despite a peak GMP of one hundred eight, the IPO’s GMP plummeted to zero before listing, highlighting the ephemeral nature of early enthusiasm.
Singh echoes Tibrewal’s sentiments, urging retail investors to view GMP as market noise rather than a definitive decision-making tool. He underscores that GMP, being an informal sentiment indicator, fails to capture true institutional demand or accurately forecast listing day outcomes.
The allure of GMP lies in its perceived simplicity, with investors often equating high figures to promising listing gains, despite its lack of official validation. Singh delves into the psychology behind this perception, noting that the apparent certainty offered by GMP appeals to new investors seeking quick profits.
However, caution is advised by Kanan Bahl, Editor-in-chief of 1 Finance Magazine, who warns against blindly following company-specific IPO narratives driven by GMP, as actual returns may not align with initial expectations.
Tibrewal points out that GMP frequently misleads retail investors, citing instances like Paytm, where a supposedly strong premium in the grey market did not translate to a favorable listing price. Singh underscores the widening gap between GMP projections and actual listings, emphasizing the inability of GMP to account for late-breaking market events.
The unregulated nature of the grey market renders it susceptible to manipulation by a small cohort of traders, a concern shared by Singh, who highlights the informal platform’s susceptibility to inflated premiums and misinformation.
In contrast to GMP, the final listing price is primarily influenced by genuine institutional demand from qualified institutional buyers and anchor investors. Singh and Tibrewal emphasize the importance of focusing on fundamental indicators such as business strength, prospectus details, and valuation metrics rather than fixating on GMP fluctuations.
While social media amplifies GMP discussions, often devoid of context, Singh and Tibrewal caution against the blind reliance on GMP figures, especially for first-time investors vulnerable to perceived quick gains.
In advocating for greater regulatory oversight, Tibrewal and Singh support initiatives to enhance transparency in GMP tracking and emphasize the need for investor responsibility grounded in fundamental analysis.
Ultimately, GMP should be viewed as supplementary information rather than a definitive investment guide, as it represents only a fraction of market sentiment and may not accurately reflect listing day realities. As the IPO landscape continues to evolve, a deeper understanding of GMP’s limitations becomes essential for informed investment decisions.